Redhill Biopharma
RDHL
#11057
Rank
HK$37.59 M
Marketcap
HK$4.23
Share price
-6.75%
Change (1 day)
-68.03%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: HK$37.59 Million

As of October 2026 Redhill Biopharma has a market cap of HK$37.59 Million. This makes Redhill Biopharma the world's 11057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$37.59 M-16.77%
2025HK$45.16 M-34.25%
2024HK$68.69 M-69.38%
2023HK$0.22 B124.39%
2022HK$99.97 M-90.52%
2021HK$1.05 B-55.35%
2020HK$2.36 B41.61%
2019HK$1.66 B35.23%
2018HK$1.23 B44.32%
2017HK$0.85 B-38.26%
2016HK$1.38 B9.04%
2015HK$1.26 B39.65%
2014HK$0.90 B54.2%
2013HK$0.58 B

End of Day market cap according to different sources

On Oct 10th, 2026 the market cap of Redhill Biopharma was reported to be:

HK$25.72 Million
by Nasdaq info icon info icon
HK$37.59 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
HK$753.43 B 2,004,158.67%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$2.818 T 7,498,555.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$731.07 B 1,944,670.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$376.15 B 1,000,526.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
HK$12.67 B 33,613.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel